The board of directors of CANbridge Pharmaceuticals Inc. announced that the principal place of business of the Company in Hong Kong will be changed to Room B01, 20/F, CITIC Tower, 1 Tim Mei Avenue, Admiralty, Hong Kong with effect from April 15, 2024. The website of the Company remain unchanged.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.33 HKD | 0.00% | 0.00% | -66.67% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-66.67% | 17.95M | |
+7.39% | 72.09B | |
+15.93% | 9.05B | |
-22.81% | 4.4B | |
+17.59% | 4.39B | |
+25.93% | 3.94B | |
+4.64% | 2.1B | |
+9.09% | 1.97B | |
-36.86% | 1.87B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 1228 Stock
- News CANbridge Pharmaceuticals Inc.
- CANbridge Pharmaceuticals Inc. Announces Change of Principal Place of Business in Hong Kong, Effect from April 15, 2024